29786-42-3

Usage

Uses

Used in Organic Synthesis:
1-(2-(trifluoromethyl)phenyl)cyclobutane-1-carbonitrile is used as an intermediate in organic synthesis for its structural features and potential reactivity, which can be exploited to create a variety of other compounds.
Used in Pharmaceutical Industry:
In the pharmaceutical industry, 1-(2-(trifluoromethyl)phenyl)cyclobutane-1-carbonitrile is used as a building block for the development of new drugs, leveraging its unique structural properties to design molecules with specific biological activities.
Used in Materials Science:
1-(2-(trifluoromethyl)phenyl)cyclobutane-1-carbonitrile is also used in materials science as a component in the development of novel materials, taking advantage of its structural characteristics to enhance material properties such as strength, flexibility, or chemical resistance.
(Note: The specific uses and properties of 1-(2-(trifluoromethyl)phenyl)cyclobutane-1-carbonitrile would need to be determined through further research and testing, as the provided materials do not detail its exact applications.)

Upstream product

• 109-64-8 1,3-dibromo-propane 
• 3038-47-9 2-(trifluoromethyl)phenylacetonitrile 
• 78-75-1 1,2-Dibromopropane 

Downstream Products

• 940868-59-7 1-(2-(trifluoromethyl)phenyl)cyclobutanecarbaldehyde 
• 29786-27-4 (<1-(α,α,α-Trifluoro-o-tolyl)cyclobutyl>carbonyl)carbamsaeureethylester 
• 29786-22-9 (<1-(α,α,α-Trifluoro-o-tolyl)cyclobutyl>carbonyl)carbamsaeuremethylester 
• 29770-38-5 (<1-(α,α,α-Trifluor-o-tolyl)-cyclobutyl>-carbonyl)-harnstoff 
• 29786-63-8 <1-(α,α,α-Trifluor-o-tolyl)-cyclobutyl>-carbonylisocyanat 

Relevant academic research and scientific papers

Oxadiazole Amine Derivative Compounds as Histone Deacetylase 6 Inhibitor, and the Pharmaceutical Composition Comprising the same

The present invention relates to a novel compound having an activity of inhibiting histone deacetylase 6 (HDAC6), an optical isomer thereof or a pharmaceutically acceptable salt thereof, a use thereof for preparation of a drug for treatment, a pharmaceutical composition comprising the same, a treatment method using the composition, and a method for preparing the same. The novel compound, an optical isomer thereof or a pharmaceutically acceptable salt thereof according to the present invention has an activity of inhibiting histone deacetylase 6 (HDAC6), and is effective for preventing or treating HDAC6-related diseases, including infectious diseases; neoplasm; endocrine, nutritional and metabolic diseases; mental and behavior disorders; nerve disorders; eye and adnexa diseases; cardiovascular diseases; respiratory diseases; digestive organ diseases; skin and subcutaneous tissue diseases; musculoskeletal and connective tissue diseases; or congenital malformation, deformation and chromosomal abnormality.COPYRIGHT KIPO 2017

Glucocorticoid receptor modulators as antiinflammatory agents

The present invention relates to compounds of formula I: wherein A, X, R1, R2 and R3 are as defined herein and pharmaceutically acceptable salts thereof. The invention also relates to methods of using the compounds of form

Propionamide compounds as antiinflammatory agents

The present invention relates to compounds of formula I: wherein R1, R2 and R3 are as defined herein and pharmaceutically acceptable salts thereof The invention also relates to methods of using the compounds of formula I a